4.6 Review

Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis

Related references

Note: Only part of the references are listed.
Editorial Material Immunology

Invasive Fungal Disease Complicating Coronavirus Disease 2019: When It Rains, It Spores

Martin Hoenigl

CLINICAL INFECTIOUS DISEASES (2021)

Review Infectious Diseases

Invasive mould disease in fatal COVID-19: a systematic review of autopsies

Brittany E. Kula et al.

Summary: Evaluation of autopsy series of COVID-19 decedents showed that invasive mould disease, including COVID-19-associated pulmonary aspergillosis, is a rare finding, only occurring in 2% of cases.

LANCET MICROBE (2021)

Article Medicine, General & Internal

Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19

Shruti Gupta et al.

Summary: A multicenter cohort study found that early treatment with tocilizumab may reduce mortality among critically ill patients with COVID-19. Further research from randomized clinical trials is needed to confirm these findings.

JAMA INTERNAL MEDICINE (2021)

Article Critical Care Medicine

Occurrence of Invasive Pulmonary Fungal Infections in Patients with Severe COVID-19 Admitted to the ICU

Arnaud Fekkar et al.

Summary: This study examined the occurrence of invasive fungal respiratory superinfections in severe COVID-19 patients admitted to five ICUs in France, finding that patients with no underlying immunosuppression seem at low risk of invasive fungal secondary infection.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)

Article Dermatology

Prevalence of opportunistic invasive aspergillosis in COVID-19 patients with severe pneumonia

Gonzalo Segrelles-Calvo et al.

Summary: As the COVID-19 pandemic continues to spread globally, the risk of invasive fungal infections as a coinfection poses a significant threat to severely ill patients. Larger cohort studies are necessary to investigate the impact of COVID-19 immunosuppressive therapy on the development of aspergillosis.

MYCOSES (2021)

Article Medicine, General & Internal

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

Carlos Salama et al.

Summary: Among hospitalized patients with Covid-19 pneumonia not on mechanical ventilation, tocilizumab reduced the risk of progression to mechanical ventilation or death, but did not improve overall survival. There were no new safety concerns identified.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Review Infectious Diseases

State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia

Woon H. Chong et al.

Summary: The incidence of secondary pulmonary infections in hospitalized COVID-19 patients is low, with bacterial infections at 16% (4.8-42.8%) and fungal infections at 6.3% (0.9-33.3%). These infections are predominantly seen in critically ill patients, with common bacterial microorganisms including Pseudomonas aeruginosa and Staphylococcus aureus, while Aspergillus fumigatus is the most common microorganism causing fungal infections. The time to diagnose these infections is around 10 days from initial hospitalization.

INFECTION (2021)

Article Dermatology

Systematic screening for COVID-19 associated invasive aspergillosis in ICU patients by culture and PCR on tracheal aspirate

Rebecca van Grootveld et al.

Summary: A study found that 24% of mechanically ventilated COVID-19 patients had Aspergillus species detected in respiratory samples, but only 17% were diagnosed with probable CAPA. Therefore, detection of Aspergillus in samples does not necessarily indicate infection.

MYCOSES (2021)

Review Public, Environmental & Occupational Health

Systematic Review Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review

W. H. Chong et al.

Summary: CAPA is defined as invasive pulmonary aspergillosis occurring in COVID-19 patients, with a high mortality rate of 48.4%. The diagnosis is limited by lack of standardized criteria, necessitating further research to determine the optimal diagnostic approach.

JOURNAL OF HOSPITAL INFECTION (2021)

Article Infectious Diseases

COVID-19-associated invasive pulmonary aspergillosis in a tertiary care center in Mexico City

Mariana Velez Pintado et al.

Summary: Patients with COVID-19-associated invasive pulmonary aspergillosis (CAPA) tend to require invasive mechanical ventilation more frequently and have a higher mortality rate. Adequate management resources can improve their outcome.

MEDICAL MYCOLOGY (2021)

Article Multidisciplinary Sciences

Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: Results from the prospective AspCOVID-19 study

Tobias Lahmer et al.

Summary: This study evaluated the incidence, risk factors, and outcome of invasive pulmonary aspergillosis (IPA) in critically ill patients with severe COVID-19 pneumonia. Results showed that COVID-19 was independently associated with IPA, which had a high mortality rate. Standardized screening and diagnostic approaches can aid in early detection of IPA in affected patients.

PLOS ONE (2021)

Article Medicine, General & Internal

The evolution of invasive pulmonary aspergillosis on chest imaging in response to antifungal therapy

Woon H. Chong et al.

BMJ CASE REPORTS (2021)

Article Critical Care Medicine

Ventilator-associated pneumonia in critically ill patients with COVID-19

Mailis Maes et al.

Summary: This study found that COVID-19 patients were more likely to develop VAP, with 3 cases of invasive aspergillosis identified among them and herpesvirade activation being more frequent. The causative organisms of secondary pneumonia observed were similar between COVID-19 and non-COVID-19 patients, suggesting a link to pulmonary dysbiosis caused by COVID-19.

CRITICAL CARE (2021)

Letter Critical Care Medicine

Detection of Invasive Pulmonary Aspergillosis in COVID-19 with Nondirected BAL

Stefaan Van Biesen et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

Article Infectious Diseases

Influenza-associated aspergillosis in critically-ill patients-a retrospective bicentric cohort study

Frederike Waldeck et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2020)

Editorial Material Respiratory System

Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis

Darius Armstrong-James et al.

EUROPEAN RESPIRATORY JOURNAL (2020)

Article Immunology

Invasive Aspergillosis as an Under-recognized Superinfection in COVID-19

George R. Thompson et al.

OPEN FORUM INFECTIOUS DISEASES (2020)

Review Microbiology

COVID-19 Associated Pulmonary Aspergillosis (CAPA)-From Immunology to Treatment

Amir Arastehfar et al.

JOURNAL OF FUNGI (2020)

Article Medicine, General & Internal

Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19 A Randomized Clinical Trial

Pierre-Francois Dequin et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Medicine, General & Internal

Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19 A Meta-analysis

Jonathan A. C. Sterne et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Rheumatology

Tocilizumab in patients with severe COVID-19: a retrospective cohort study

Giovanni Guaraldi et al.

LANCET RHEUMATOLOGY (2020)

Article Critical Care Medicine

Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study

Alexander F. A. D. Schauwvlieghe et al.

LANCET RESPIRATORY MEDICINE (2018)

Letter Critical Care Medicine

Influenza-associated Aspergillosis in Critically III Patients

Frank L. van de Veerdonk et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)

Article Respiratory System

Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease

Nuri Tutar et al.

MULTIDISCIPLINARY RESPIRATORY MEDICINE (2013)

Review Immunology

Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy

Richard S. Hotchkiss et al.

NATURE REVIEWS IMMUNOLOGY (2013)

Article Critical Care Medicine

A Clinical Algorithm to Diagnose Invasive Pulmonary Aspergillosis in Critically Ill Patients

Stijn I. Blot et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)

Editorial Material Public, Environmental & Occupational Health

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

Andreas Stang

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)

Review Respiratory System

Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease

P. Bulpa et al.

EUROPEAN RESPIRATORY JOURNAL (2007)

Article Medicine, General & Internal

Measuring inconsistency in meta-analyses

JPT Higgins et al.

BMJ-BRITISH MEDICAL JOURNAL (2003)